DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Atzpodien J, Schmitt E, Gertenbach U, Fornara P, Heynemann H, Maskow A, Ecke M, Woltjen HH, Jentsch H, Wieland W, Wandert T, Reitz M.
Adjuvant treatment with interleukin-2- and
interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour
nephrectomy: results of a prospectively randomised trial of the German
Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).
Br J Cancer 2005; 92: 843-846
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.